# Life Sciences Contract Research Outsourcing Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Healthcare Services](https://www.ihealthcareanalyst.com/reports/healthcare-services/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Life Sciences Contract Research Outsourcing Market by Service \[Drug Discovery, Clinical Trials, Preclinical, Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials (Post Marketing Surveillance), Clinical Data Management, Medical Writing Services, Regulatory Services, and Research Groups – Academic Medical Centers, Clinical Trial Laboratories, and Contract Research organizations\] and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

The increasing gap between R&D expenditure and productivity, and to survive in the competitive marketplace pharmaceutical companies are constantly outsourcing their research and development activities to focus on building core competencies. The contract research outsourcing (CRO) trend in the life sciences industry has evolved in course of time with emerging markets such as China and India are becoming attractive destinations. At the same time, availability of skilled resources in contract research units at a reasonable cost expedited the growth of the CRO sector. The global pharmaceutical industry is slowly transitioning from a vertically integrated business model to an outsourcing model where various processes such as R&D, clinical trials, medical writing, regulatory processes are outsourced. In recent times, countries of Eastern Europe, Latin America, Africa and East Asia are also adopting the contract research business model and becoming strong contenders in the outsourcing market.

The global life sciences contract research outsourcing market report provides market size ($Million 2023 to 2033), market share and forecast (CAGR%, 2025 to 2033).

The global life sciences contract research outsourcing market segmentation is based on service types such as drug discovery, clinical trials, preclinical, phase I trials, phase II trials, phase III trials, phase IV trials (post marketing surveillance), clinical data management, medical writing services, regulatory services, and research groups such as academic medical centers, clinical trial laboratories, and contract research organizations.

The global life sciences contract research outsourcing market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global life sciences contract research outsourcing market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Major players operating in the global life sciences contract research outsourcing market and included in this report are Quintiles Transnational Corporation, Covance, Inc. Parexel, Omnicare Clinical Research, and others.

**DATA INCLUDED:** Life Sciences Contract Research Outsourcing Market Size, Life Sciences Contract Research Outsourcing Market Share, Life Sciences Contract Research Outsourcing Market Growth Rates, Life Sciences Contract Research Outsourcing Market Trends, and Life Sciences Contract Research Outsourcing Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Life Sciences Contract Research Outsourcing Market by Service \[Drug Discovery, Clinical Trials, Preclinical, Phase I Trials, Phase II Trials, Phase III Trials, Phase IV Trials (Post Marketing Surveillance), Clinical Data Management, Medical Writing Services, Regulatory Services, and Research Groups - Academic Medical Centers, Clinical Trial Laboratories, and Contract Research organizations\] and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents HS](#tab-table-of-contents-hs)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-pages)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Products, Services
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
        *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Service Type
    *   Device or Equipment Type
    *   Diagnostic or Therapy Type
    *   Technology
    *   Medical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
8.  **Recommendations**
9.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Life Sciences Contract Research Outsourcing Market**

1\. **Service Type**  
1.1. Drug Discovery  
1.2. Clinical Trials  
1.2.1. Preclinical  
1.2.2. Phase I Trials  
1.2.3. Phase II Trials  
1.2.4. Phase III Trial s  
1.2.5. Phase IV Trials (Post Marketing Surveillance)  
1.3. Clinical Data Management (CDM)  
1.4. Medical Writing Services  
1.5. Regulatory Services  
1.6. Others

2\. **Research Organizations**  
2.1. Academic Medical Centers (AMCs)  
2.2. Clinical Trial Laboratories (CTLs)  
2.3. Contract Research Organizations (CROs)

3\. **Geography (Region, Country)**  
3.1. North America (U.S., Canada)  
3.2. Latin America (Brazil, Mexico, Rest of LA)  
3.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
3.4. Asia Pacific (Japan, China, India, Rest of APAC)  
3.5. Rest of the World

4\. **Company Profiles**  
5\. Charles River Laboratories International Inc.  
6\. Covance, Inc.  
7\. Icon, Plc  
8\. Inventiv Health, Inc.  
9\. Medidata Solutions, Inc.  
10\. Parexel International Corporation  
11\. Pharmaceutical Product Development, Inc.  
12\. Quintiles Transnational Corporation

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#a2d1c3cec7d1e2cbcac7c3ced6cac1c3d0c7c3ccc3cedbd1d68cc1cdcf)

[](# "Scroll back to top")

Search for: